Invicta Diagnostic
add_icon

Invicta Diagnostic

66.85
-3.50
(-4.98%)
Market Cap
84.04 Cr
PE Ratio
18.13
Volume
1,10,400.00
Day High - Low
73.75 - 66.85
52W High-Low
105.00 - 58.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
84.04 Cr
EPS
4.90
PE Ratio
18.13
PB Ratio
1.77
Book Value
39.71
EBITDA
9.76
Dividend Yield
0.00 %
Return on Equity
29.63
Debt to Equity
0.12
Forecast For
Actual

Company News

View All News
Caret
positive
Invicta Diagnostic Limited expanded its tele-radiology services to the United States on May 22, 2026, marking its entry into the international market.
neutral
Invicta Diagnostic Limited completed the sale of its 47% stake in Porteus Medical LLP for ₹47000. The transaction was finalized on May 16, 2026.
neutral
Invicta Diagnostic Limited will hold an earnings conference call on May 23, 2026, to discuss its performance for the half-year ended March 31, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,614.90
#1 27,058.46
53.50
#1 2,762.90
8.15
#1 510
-14.98
57.10
1,220.40
12,557.52
72.87
814.20
16.36
182
37.25
55.51
524.50
10,874.34
56.27
1,645.85
22.25
185
74.66
57.49
493.15
7,849.24
45.59
829.04
18.06
156
125.46
69.18
620.10
6,222.13
79.31
998.85
29.74
62
22.09
60.28
553.85
1,796.62
22.68
742.70
16.70
78
-21.13
34.34
298.50
1,554.61
51.38
310.41
21.30
34
-13.89
53.40
1,236.20
1,060.99
17.70
111.60
28.72
48
65.93
45.20
322.45
1,025.73
33.22
1,170.80
-18.47
-134
101.06
69.84
451.70
882.77
#1 14.78
147.80
#1 134.60
19
#1 520.00
43.09
Growth Rate
Revenue Growth
5.37 %
Net Income Growth
14.89 %
Cash Flow Change
53.68 %
ROE
22.79 %
ROCE
85.17 %
EBITDA Margin (Avg.)
-5.41 %

Yearly Financial Results

Annual Financials
2024
2025
2026
TTM
Revenue
8
31
32
0
Expenses
5
21
23
0
EBITDA
4
10
10
0
Operating Profit %
43 %
30 %
30 %
0 %
Depreciation
1
3
3
0
Interest
0
0
0
0
Profit Before Tax
3
7
7
0
Tax
0
2
2
0
Net Profit
3
5
5
0
EPS in ₹
3.19
5.57
4.90
0.00

Balance Sheet

Balance Sheet
2024
2025
2026
Total Assets
16
21
60
Fixed Assets
12
10
19
Current Assets
4
6
34
Capital Work in Progress
0
0
0
Investments
0
0
1
Other Assets
4
12
0
Total Equity & Liabilities
16
21
60
Current Liabilities
2
2
7
Non Current Liabilities
3
3
3
Total Equity
11
16
50
Reserve & Surplus
12
8
37
Share Capital
0
8
13

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
1
1
Investing Activities
-10
-5
Operating Activities
4
7
Financing Activities
7
-0

Share Holding

% Holding
Aug 2024
Nov 2025
Dec 2025
Mar 2026
Promoter
100.00 %
90.52 %
66.70 %
66.70 %
FIIs
0.00 %
0.00 %
0.94 %
4.20 %
DIIs
0.00 %
0.00 %
10.22 %
4.30 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
18.49 %
18.71 %
Others
0.00 %
9.48 %
3.66 %
6.10 %
No of Share Holders
14
34
34
411

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
17 Apr 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
17 Apr 2026 71.25 73.20
18 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
18 May 2026 86.10 89.50

Technical Indicators

RSI(14)
Neutral
35.84
ATR(14)
Less Volatile
4.49
STOCH(9,6)
Oversold
5.22
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-2.96
ADX(14)
Weak Trend
22.61
UO(9)
Bullish
27.13
ROC(12)
Downtrend And Accelerating
-26.68
WillR(14)
Oversold
-100.00